Maverick Capital’s Colgate-Palmolive CL Stock Holding History

Maverick Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,670	Closed	-$764K	–	261
2025 Q4	$764K	Sell	9,670 -19,912	-67%	-$1.56M	0.01%	167
2025 Q3	$2.36M	Buy	+29,582	New	+$2.52M	0.03%	155
2024 Q2	–	Sell	-3,680	Closed	-$331K	–	307
2024 Q1	$331K	Buy	+3,680	New	+$312K	0.01%	325
2023 Q4	–	Sell	-10,449	Closed	-$743K	–	373
2023 Q3	$743K	Buy	+10,449	New	+$781K	0.02%	144
2019 Q4	–	Sell	-51,602	Closed	-$3.79M	–	358
2019 Q3	$3.79M	Buy	51,602 +7,332	+17%	+$532K	0.06%	205
2019 Q2	$3.17M	Buy	+44,270	New	+$3.14M	0.05%	207
2018 Q2	–	Sell	-36,820	Closed	-$2.64M	–	253
2018 Q1	$2.64M	Buy	+36,820	New	+$2.65M	0.03%	179
2016 Q3	–	Sell	-45,170	Closed	-$3.31M	–	133
2016 Q2	$3.31M	Buy	+45,170	New	+$3.22M	0.04%	40

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Maverick Capital's CL Position: Q1 2026 in Review

Maverick Capital sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 9,670 shares — an estimated $764K sold.

Maverick Capital first reported a position in CL in Q2 2016 and held it in 8 quarters. The position peaked at $3.79M in Q3 2019. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Maverick Capital reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Maverick Capital sold 9,670 Colgate-Palmolive shares in Q1 2026, an estimated $764K.
Maverick Capital first reported a position in Colgate-Palmolive in Q2 2016 and held it in 8 quarters.
Maverick Capital's Colgate-Palmolive position peaked at $3.79M in Q3 2019.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.